1 Oct 2020

Cerbios offers high quality tailor-made programs for biopharmaceuticals

PDF 707 kB

From cloning to cGMP production, Cerbios meets your product development and manufacturing needs for recombinant proteins, monoclonal antibodies (mAbs) and novel mAbs derivatives including fragments and Bispecific.

Content provided by our supplier

Cerbios-Pharma SA

  • CH
  • 2015
    On CPHI since
  • 100 - 249
Company types

Other Content from Cerbios-Pharma SA (4)

  • News Cerbios-Pharma boosts ADC bioconjugation service

    Cerbios expanded its ADCs and Bioconjugation capabilities to accomodate increasing technological and market demand. Building further capacities on top of the already solid platform provided by the Proveo Alliance, Cerbios is keeping ahead of the technological advances and is able to offer a tailored experience in novel payloads and ADC scaffolds.
  • Brochure High Potency Active Ingredients CDMO Services

    Cerbios is highly qualified in process development of new APIs and HPAPIs for preclinical, clinical and commercial supply. Cerbios is the ideal and reliable partner for your New Chemical Entity (NCE), NDA submission and commercial manufacturing.
  • Brochure ADCs Toxin and Conjugation CDMO Services

    Offered Services: Process and Analytical Development cGMP Manufacturing in the Fully Integrated site of Lugano Complete Regulatory Documentation for IND submission and NDA Commercial Supply